Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients

International Journal of Dermatology

Volumn 45, Issue 5, 2006, Pages 547-553

  Pérez Lorenzo, Rolando ^a   Núñez Oreza, Luis Alberto ^a   Garma Quen, Patricia Margarita ^a   López Pacheco, Eduardo ^a   Bricaire Bricaire, Guadalupe ^a  

^a UNIVERSIDAD AUTÓNOMA DE CAMPECHE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; M PROTEIN;

ADULT; AGED; ARTICLE; BACTERIAL IMMUNITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PSORIASIS; REGULATORY T LYMPHOCYTE; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PYOGENES; TH1 CELL; TH2 CELL;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PSORIASIS; STREPTOCOCCUS PYOGENES; TH1 CELLS; TH2 CELLS;

EID: 33646200907     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02528.x     Document Type: Article

References (48)

1. Prinz JC. Psoriasis vulgaris, streptococci and the immune system: A riddle to be solved soon? Scand J Immunol 1997; 45: 583-586.
2. Schön MP. Animal models of psoriasis-What can we learn from them?. J Invest Dermatol 1999; 112: 405-410.
3. Weinstein GD, Frost P. Abnormal cell proliferation in psoriasis. J Invest Dermatol 1968; 50: 254-259.
4. Barker JNWN. The pathophysiology of psoriasis. The Lancet 1991; 338: 227.
5. Bos JD, De Rie MA. The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today 1999; 20: 40-46.
6. Rosemberg EW, Noah PW. The Koebner phenomenon and the microbial basis of psoriasis. J Am Acad Dermatol 1988; 18: 151-158.
7. Skinner RB, Rosemberg W, Noah P. Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans. Acta Derm Venereol (Stockh) 1994; 74 (Suppl): 149.
8. Bianchi G, Buffrini L, Grignolo MC, et al. Psoriasis and lyme arthritis. Acta Derm Venereol (Stockh) 1994; 74 (Suppl): 119.
9. Squiqueira L, Galimberti R, Morelli L, et al. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol 1994; 19: 289.
10. Bour H, Demidem A, Garrigue JL, et al. T cell response to staphylococcal enterotoxin B superantigen in chronic plaque psoriasis. Acta Derm Venereol (Stockh) 1995; 75: 218-221.
11. Valdimarsson H, Baker BS, Jónsdóttir I, et al. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145-149.
12. Pérez-Lorenzo R, Zambrano-Zaragoza JF, Saúl A, et al. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol 1998; 37: 524-531.
13. Villeda-Gabriel G, Santamaría-Cogollos LC, Pérez-Lorenzo R, et al. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis. Arch Med Res 1998; 29: 143-148.
14. Baker BS, Powles AV, Malkeni AK, et al. Altered cell-mediated immunity to group A haemolytic streptococcal antigens in psoriasis. Br J Dermatol 1991; 125: 34-42.
15. Baker BS, Brown DW, Fischetti VA, et al. Skin T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis. Clin Exp Immunol 2001; 124: 516-521.
16. Pérez-Lorenzo R, Zambrano-Zaragoza JF, Moo-Castillo K, et al. IgG class antibodies to heat shock-induced streptococcal antigens in psoriatic patients. Int J Dermatol 2003; 42: 110-115.
17. Bos JD. The pathomechanisms of psoriasis, the skin immune system and cyclosporin. Br J Dermatol 1988; 118: 141.
18. Elder JT, Henseler T, Christophers E, et al. of genes and antigens: The inheritance of psoriasis. J Invest Dermatol 1994; 103 (Suppl): 150S-153S.
19. Barker JNWN. Pathogenesis of psoriasis. J Dermatol 1998; 25: 778-781.
20. Gottlieb AB. Immunologic mechanims in psoriasis. J Am Acad Dermatol 1988; 18: 1376-1380.
21. Glinski W, Obalek S, Lagner A, et al. Defective Function T Lymphocytes Psoriasis. J Invest Dermatol 1978; 70: 105-110.
22. Baker BS, Swain AF, Fry L, et al. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984; 110: 555-564.
23. Nicolas JF, Bour H, Thivolet J, et al. Immunotherapy of psoriasis with anti-CD4 monoclonal antibodies. Arch Derm Venereol (Stockh) 1994; 74 (Suppl): 180.
24. Talme T, Lund-Rosell B, Sundquist KG, et al. A new treatment for psoriasis? A review of our experiences. Acta Derm Venereol (Stockh) 1994; 74 (Suppl): 76-78.
25. Ockenfels HM, Schultewolter T, Ockenfels G, et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139: 390-395.
26. Mossmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
27. van der Pouw-Kraan T, van Kooten C, Rensink I, et al. Interleukin (IL) -4 production by human T cells: Differential regulation of IL-4 vs. IL-2 production. Eur J Immunol 1992; 22: 1237-1241.
28. Mahmoud F, Abul H, Al-Seleh Q, et al. Differential expression of interferon gamma by mitogen-stimulated peripheral blood mononuclear cells among Kuwaiti psoriasis patients. J Dermatol 1999; 26: 23-28.
29. Manjula BN, Trus BL, Fischetti VA. Presence of two distinct regions in the coiled-coil structure of the streptococcal PepM5 protein: Relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci USA 1985; 48: 1064-1068.
30. Saúl A. Lecciones de Dermatología 14th edn. Mexico: Méndez Editores S.A. De CV, 2001: 483-484.
31. Fleischer B, Schmidt KM, Gerlach D, et al. Separation of T-cell-stimulating activity from streptococcal M protein. Infect Immun 1992; 60: 1767-1770.
32. Beachey EH, Campbell GL, Ofek I. Peptic digestion of streptococcal M protein II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun 1974; 9: 891-896.
33. Beachey EH, Stollerman GH, Chiang EY, et al. Purification and properties of M protein extracted from group A streptococci with pepsin: Covalent structure of the amino terminal region of type 24 M antigen. J Exp Med 1977; 145: 1469-1472.
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254.
35. Rusell CA, Vindelov LL. Optimization and comparison of the MTT assay and the 3 H-TdR assay for the detection of IL-2 in helper T cell proliferation assays. J Immunol Meth 1998; 217: 165-175.
36. Guilhou JJ, Mynadier J, Clot J, et al. Immunological aspects of psoriasis II. Dissociated impairment of thymus dependent lymphocytes. Br J Dermatol 1976; 95: 295-301.
37. Baker BS, Brown D, Fischetti VA, et al. Stronger proliferative response to membrane versus cell-wall streptococcal proteins by peripheral blood T cells in chronic plaque psoriasis. Scand J Immunol 2001; 54: 619-625.
38. Baker BS, Bokth S, Garioch JJ, et al. Decreased T cell reactivity to tripsinized group A streptococci in psoriasis. Acta Derm Venereol (Stockh) 1994; 74: 276-278.
39. Fischetti VA, Jones KF, Scott JR. Size variation of the M protein in group A streptococci. J Exp Med 1985; 161: 1384-1401.
40. Baker BS. Recent Advances in Psoriasis: The Role of the Immune System. London: UK. Imperial College Press, 2000: 61-89, 161.
41. Gerli R, Bistoni O, Russano A, et al. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 2002; 129: 549-555.
42. Gross N, Prinz JC. A subpopulation of T lymphocytes prepared from psoriatic skin lesions enhances proliferation of keratinocytes in vitro via secreted products. Acta Derm Venereol (Stockh) 1994; 74 (Suppl): 13.
43. Mocellin S, Panelli MC, Wang E, et al. The dual role of IL-10. Trends Immunol 2003; 24: 36-43.
44. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
45. Asadullah K, Sterry W, Stephanek K, et al. IL-10 is a key cytokine in psoriasis. Proff of principle by IL-10 therapy: A new therapeutic approach. J Clin Invest 1998; 101: 783-794.
46. Bach JF. Non-Th2 regulatory T-cell control of Th1 autoimmunity. Scand J Immunol 2001; 54: 21-29.
47. Woodrow JC, David VK, Usher N, et al. The HL-A System and psoriasis. Br J Dermatol 1975; 92: 427-436.
48. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456.